I. Strokov

发表

The association of the TP53 polymorphisms Pro72Arg and C(−594)CC with diabetic polyneuropathy in Russian Muscovites with type 1 diabetes mellitus

V. Nosikov, E. Spitsina, N. Yakunina, 2007, Molecular Biology.

Association of polymorphic markers of the lipid metabolism genes with diabetic polyneuropathy in type 1 diabetes mellitus

N. Yakunina, I. Strokov, O. E. Voron’ko, 2005, Molecular Biology.

The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic Acid

P. O'Brien, W. Litchy, P. Dyck, 2003 .

The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

P. O'Brien, W. Litchy, P. Dyck, 2003, Diabetes care.

The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients.

I. Strokov, D. Chistiakov, V. Nosikov, 2006, Diabetes & metabolism.

Management of patients with neurological complications of diabetes mellitus

I. Strokov, O. V. Kosivtsova, E. N. Chuprina, 2020, Meditsinskiy sovet = Medical Council.

Early diagnostics of diabetes mellitus using noninvasive imaging by computer capillaroscopy

Konstantin V. Ovsyannickov, I. Strokov, A. Ametov, 2002 .

[Segawa's syndrome].

A. V. Muranova, I. Strokov, O. N. Voskresenskaya, 2019, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Association of Polymorphic Markers of the Antioxidant Enzyme Genes with Diabetic Polyneuropathy in Type 1 Diabetes Mellitus

D. A. Chistyakov, I. Strokov, K. Savost’yanov, 2004, Molecular Biology.

[Early diagnosis of diabetic polyneuropathy based on the results of corneal nerve fibers examination].

I. Strokov, S. Avetisov, Z. Surnina, 2020, Vestnik oftalmologii.

Effect of naftidrofuryl on lipid peroxidation in serum and erythrocyte plasma membrane of patients with diabetes mellitus

I. Strokov, A. Kubatiev, T. S. Balashova, 1996, Bulletin of Experimental Biology and Medicine.

Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER)

I. Strokov, A. Verbovoy, Y. Shvarts, 2022, BMJ Open Diabetes Research & Care.

[Diabetic and non-diabetic neuropathies in patients with diabetes mellitus].

I. Strokov, A. Barinov, L. T. Akhmedzhanova, 2018, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Polymorphic markers of the NO synthase genes and genetic predisposition to diabetic polyneuropathy in type 1 diabetes mellitus

V. Nosikov, I. Strokov, O. E. Voron’ko, 2005, Molecular Biology.

Association of the SOD2 Ala(–9)Val and SOD3 Arg213Gly Polymorphisms with Diabetic Polyneuropathy in Diabetes Mellitus Type 1

D. A. Chistyakov, I. Strokov, V. Nosikov, 2003, Molecular Biology.

Diagnosis of diabetic polyneuropathy in primary care

O. S. Davydov, I. Strokov, M. Churyukanov, 2021, Russian Journal of Pain.

Diagnosis and rational treatment of painful diabetic peripheral neuropathy: an interdisciplinary expert consensus

I. Strokov, M. Shestakova, M. Churyukanov, 2019, Diabetes mellitus.

The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients

V. Nosikov, I. Strokov, M. Babizhayev, 2015, Cell Biochemistry and Biophysics.

Treatment of Symptomatic Polyneuropathy With Actovegin in Type 2 Diabetic Patients

I. Strokov, D. Ziegler, B. Mankovsky, 2009, Diabetes Care.

Discogenic lumbosacral radiculopathy. Recommendations of the Russian Association for the Study of Pain (RSSP)

E. R. Barantsevich, A. Belova, I. Strokov, 2020 .

[α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy].

I. Strokov, A. S. Phokina, 2017, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Predictors of response to treatment with actovegin for 6 months in patients with type 2 diabetes and symptomatic polyneuropathy.

I. Strokov, D. Ziegler, N. Papanas, 2017, Journal of diabetes and its complications.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Association of the POLG1 T(−365)C, ANT1 G(−25)A, and PEO1 G(−605)T polymorphisms with diabetic polyneuropathy in patients with Type 1 diabetes mellitus

V. Nosikov, E. Spitsina, D. A. Chudakova, 2009, Molecular Biology.

Protein spectrum of blood plasma in patients with diabetes mellitus type II

I. Strokov, R. Ziganshin, V. Shender, 2018, Journal of Cellular Biotechnology.

Laboratory diagnosis of peripheral autonomic failure of various origins

I. Strokov, E. Sepp, V. B. Lantsova, 2020 .

[Association of the SOD2 Ala(-9)Val and SOD3 Arg213Gly polymorphisms with diabetic polyneuropathy in patients with diabetes mellitus type 1].

I. Strokov, D. Chistiakov, V. Nosikov, 2003, Molekuliarnaia biologiia.

Leu54Phe and Val762Ala polymorphisms in the poly(ADP-ribose)polymerase-1 gene are associated with diabetic polyneuropathy in Russian type 1 diabetic patients.

V. Nosikov, D. A. Chudakova, I. Strokov, 2008, Diabetes research and clinical practice.

Possibilities of early diagnosis of diabetic polyneuropathy based on the study of corneal nerve fibers

I. Strokov, S. Avetisov, Z. Surnina, 2020 .

The Function of Endogenous Protective Systems in Patients with Insulin-Dependent Diabetes Mellitus and Polyneuropathy: Effect of Antioxidant Therapy

I. Strokov, E. Manukhina, A. Ametov, 2000, Bulletin of Experimental Biology and Medicine.

A Splice Variant of GNB3 and Peripheral Polyneuropathy in Type 1 Diabetes

V. Nosikov, E. Spitsina, I. Strokov, 2009, Disease markers.

A splice variant of GNB 3 and peripheral polyneuropathy in type 1 diabetes

V. Nosikov, E. Spitsina, I. Strokov, 2014 .

Asplic evarian to fGNB3 an dperipheral polyneuropathy in type 1 diabetes

V. Nosikov, E. Spitsina, I. Strokov, 2009 .

MITOCHONDRIAL CYTOPATHIES: MELAS AND MIDD SYNDROMES. ONE GENETIC DEFECT - DIFFERENT CLINICAL APPEARANCES

A. V. Muranova, I. Strokov, 2017 .

[Association of polymorphous markers Pro72Arg and C(-594)CC OF TP53 gene with diabetic polyneuropathy in patients with type 1 diabetes mellitus living in Moscow].

V. Nosikov, E. Spitsina, D. A. Chudakova, 2007, Molekuliarnaia biologiia.

[Role of diabetic neuropathy in development of diabetic foot syndrome].

I. V. Mironova, I. Strokov, I. V. Gur'eva, 1998, Klinicheskaia meditsina.

Сomprehensive assessment of macro- and microcirculation parameters in patients with type 2 diabetes mellitus and subclinical stage of diabetic peripheral neuropathy during treatment with antihypoxic drug

I. Strokov, Y. P. Sych, M. Kalashnikova, 2022, Russian neurological journal.

Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: a population-based case-control study

O. I. Drepa, V. Nosikov, I. Strokov, 2003, Acta Diabetologica.

['Point of no return' in diabetic neuropathies: a dangerous delusion].

I. Strokov, S. Kopishinskaya, L. Akhmadeeva, 2019, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[Search for the association of polymorphic markers for genes coding for antioxidant defense enzymes, with development of diabetic polyneuropathies in patients with type 1 diabetes mellitus].

I. Strokov, D. Chistiakov, V. Nosikov, 2004, Molekuliarnaia biologiia.